Optimal Dose of Gell Peptide for Diabetic Wound Healing

Various studies show that diabetes cases are increasing. Epidemiological data also reported 10.7 million in Indonesia 2019. Diabetic foot syndrome is a common complication individuals with DM. Its treatment costly and prolonged. Thus, we conducted an vivo study to assess the optimal peptide dose its effectiveness accelerating diabetic wound healing. This experimental laboratory randomized pre-post test control group design was Wistar rats wounds receiving different doses of gel peptides. One Way Anova applied compare three gell (0.05 gr, 0.1 0.15 gr). The significance level determined P<0.05. Significant improvement all groups started on day 7 (p=0.000). best outcome obtained B, which had complete closure gr effective for healing closure.